You just read:

Bridge BioResearch Announces the Approval of the Phase 2a Trial Protocol of Isoniazid - a Novel Treatment of Chronic Ulcers

News provided by

Bridge BioResearch Plc

19 Jan, 2012, 11:16 GMT